4

FORM 4 SUBMISSION

Company: Viridian Therapeutics, Inc.\DE
Filed: January 15, 2021
Period of Report: October 15, 2020
Accession Number: 0000899243-21-002233

View Document ↗ View on SEC.gov ↗